Guardion Health Sciences (GHSI) Stock Price, News & Analysis

Company Overview

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Key Stats

• Today's Range: $3.22 to $3.29
• 50-Day Range: $3.22 to $3.50
• 52-Week Range: $3.04 to $18.00
• Volume: 4,700 shs
• Average Volume: 105,261 shs
• Market Capitalization: $4.35 million
• P/E Ratio: 0.66
• Dividend Yield: 155.28%
• Price Target: N/A
• Consensus Rating: N/A

GHSI Stock Analysis - Frequently Asked Questions

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences, Inc. (NASDAQ:GHSI) released its earnings results on Monday, August, 12th. The company reported ($42.00) earnings per share for the quarter. The business earned $0.26 million during the quarter. Guardion Health Sciences had a negative trailing twelve-month return on equity of 73.69% and a net margin of 22.79%.

When did Guardion Health Sciences' stock split?

Guardion Health Sciences shares reverse split on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

When did Guardion Health Sciences IPO?

Guardion Health Sciences (GHSI) raised $6 million in an initial public offering on Friday, April 5th 2019. The company issued 1,500,000 shares at a price of $4.00 per share. WallachBeth Capital and Westpark Capital served as the underwriters for the IPO.

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardion Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Acasti Pharma (ACST), iBio (IBIO) and General Electric (GE).

Company Calendar

• Last Earnings: 8/12/2019
• Today: 3/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:GHSI
• CIK: 1642375
• Web: www.guardionhealth.com
• Phone: (800) 873-5141
• Fax: 858-630-5543
• Employees: 10
• Year Founded: 2009

Profitability

• EPS (Most Recent Fiscal Year): $4.87
• Trailing P/E Ratio: 0.66
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $160,000.00
• Net Margins: 22.79%
• Pretax Margin: -20.29%
• Return on Equity: -73.69%
• Return on Assets: -48.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 16.68
• Quick Ratio: 16.59

Sales & Book Value

• Annual Sales: $12.25 million
• Price / Sales: 0.35
• Cash Flow: $0.14 per share
• Price / Cash Flow: 23.15
• Book Value: $6.39 per share
• Price / Book: 0.50

Miscellaneous

• Outstanding Shares: 1,350,000
• Free Float: 1,332,000
• Market Cap: $4.35 million
• Optionable: Not Optionable
• Beta: 0.73